602 results on '"Dobs, Adrian"'
Search Results
2. Effectiveness of artificial intelligence vs. human coaching in diabetes prevention: a study protocol for a randomized controlled trial
3. Online communication skill training of patients with cancer: A test of the behavioral intention predictive framework for communication skills
4. Cancer care partners’ behavioral intention to use autonomy enhancing communication skills during accompanied visits after online skill training.
5. Amplifying Their Voices: Advice, Guidance, and Perceived Value of Cancer Biobanking Research Among an Older, Diverse Cohort
6. Transgender Women With Suppressed Testosterone Display Lower Burden of Coronary Disease Than Matched Cisgender Men.
7. Patient perspectives on cancer care during COVID-19: A qualitative study.
8. Characteristics and Longitudinal Patterns of Erectile Dysfunction Drug Use Among Men Who Have Sex with Men in the U.S.
9. Associations of Testosterone and Related Hormones With All-Cause and Cardiovascular Mortality and Incident Cardiovascular Disease in Men: Individual Participant Data Meta-analyses.
10. Male reproductive health in cystic fibrosis
11. Consumption of caffeinated beverages and serum concentrations of sex steroid hormones in US men
12. Inflammation, Immune Activation, Immunosenescence, and Hormonal Biomarkers in the Frailty-Related Phenotype of Men With or at Risk for HIV Infection
13. Psychometric Evaluation of the Hypogonadism Impact of Symptoms Questionnaire Short Form (HIS-Q-SF)
14. Development of the Hypogonadism Impact of Symptoms Questionnaire Short Form: Qualitative Research
15. Psychometric Evaluation of the Hypogonadism Impact of Symptoms Questionnaire
16. Consumption of caffeinated beverages and serum concentrations of sex steroid hormones in US men
17. Testosterone and Physical Function
18. Comparison of Insulin Resistance to Coronary Atherosclerosis in Human Immunodeficiency Virus Infected and Uninfected Men (from the Multicenter AIDS Cohort Study)
19. Leflutrozole in male obesity-associated hypogonadotropic hypogonadism: Ph 2b double-blind randomised controlled trial.
20. Factors Associated With Circulating Sex Hormones in Men: Individual Participant Data Meta-analyses.
21. An Individualized Approach to Managing Testosterone Therapy in the Primary Care Setting
22. Testosterone 2% Gel Can Normalize Testosterone Concentrations in Men with Low Testosterone Regardless of Body Mass Index
23. Debate position: cognition and mood are not improved in men administered exogenous testosterone therapy
24. Androgens and Selective Androgen Receptor Modulators to Treat Functional Limitations Associated With Aging and Chronic Disease.
25. Content Validity of the Hypogonadism Impact of Symptoms Questionnaire (HIS-Q): A Patient-Reported Outcome Measure to Evaluate Symptoms of Hypogonadism
26. Effects of enobosarm on muscle wasting and physical function in patients with cancer: a double-blind, randomised controlled phase 2 trial
27. #1783565 Double-Blind, Multiple Ascending Dose, Safety, Pharmacokinetic and Body Composition Study of Enobosarm in Healthy Young and Older Men
28. #1782591 Potential to Optimize Weight Loss with Enobosarm: Augment Reduction of Fat Mass while Preserving Muscle in Older Patients with Obesity
29. Racial/ethnic differences in serum sex steroid hormone concentrations in US adolescent males
30. Association Between Endogenous Testosterone and Cerebrovascular Disease in the ARIC Study (Atherosclerosis Risk in Communities)
31. Testosterone and abnormal glucose metabolism in an inner-city cohort
32. Association of serum cholesterol and cholesterol-lowering drug use with serum sex steroid hormones in men in NHANES III
33. Association of Cigarette Smoking, Alcohol Consumption, and Physical Activity with Sex Steroid Hormone Levels in US Men
34. A Precision Oncology Platform to Support Genotype-Tailored Therapy Selection.
35. Association of endogenous testosterone with subclinical atherosclerosis in men: the multi-ethnic study of atherosclerosis
36. LONG-TERM SAFETY AND TOLERABILITY OF ORAL TESTOSTERONE (LPCN 1021) IN HYPOGONADAL MEN: RESULTS FROM THE 52-WEEK PHASE 3 STUDY: PD50-06
37. HYPOGONADAL MEN WITH SEXUAL FUNCTION DISORDER BENEFIT FROM LPCN 1021 (ORAL TESTOSTERONE) – SOAR (STUDY OF ANDROGEN REPLACEMENT) TRIAL: MP76-10
38. Prostate Cancer in Male-to-Female Transgender Individuals: Histopathologic Findings and Association With Gender-affirming Hormonal Therapy.
39. Treatment patterns and unmet needs in adults with classic congenital adrenal hyperplasia: A modified Delphi consensus study.
40. Lower serum testosterone concentrations are associated with a higher incidence of dementia in men: The UK Biobank prospective cohort study.
41. Circulating total testosterone and PSA concentrations in a nationally representative sample of men without a diagnosis of prostate cancer
42. PD37-08 EFFICACY AND PHARMACOKINETICS OF LPCN 1021, A NOVEL ORAL TESTOSTERONE REPLACEMENT THERAPY (TRT), IN HYPOGONADAL MEN: STUDY OF ANDROGEN REPLACEMENT (SOAR)
43. Endogenous Testosterone and its Relationship to Preclinical and Clinical Measures of Cardiovascular Disease in the Atherosclerosis Risk in Communities Study
44. Lack of an Effect of High Dose Isoflavones in Men With Prostate Cancer Undergoing Androgen Deprivation Therapy
45. Effects of Erectile Dysfunction Drugs Use on T-Cells and Immune Markers on Men Who Have Sex with Men.
46. Anti-Aging Diet and Supplements: Fact or Fiction?
47. Inaccuracy of haemoglobin A1c among HIV-infected men: effects of CD4 cell count, antiretroviral therapies and haematological parameters
48. Topical Testosterone Supplementation for the Treatment of Male Hypogonadism
49. The association of endogenous sex hormones with lipoprotein subfraction profile in the Multi-Ethnic Study of Atherosclerosis
50. Heavy injection drug use is associated with lower percent body fat in a multi-ethnic cohort of HIV-positive and HIV-negative drug users from three U.S. cities
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.